Glenmark Pharmaceuticals U.S. > News

News

Press Releases

Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.

Glenmark Pharmaceuticals receives ANDA approval for Desonide Cream, 0.05%

July 25, 2017

Glenmark Pharmaceuticals Enters Exclusive Agreement with Cyndea Pharma S.L. for Generic Soft-Gelatin Capsule Drug Products

July 18, 2017

Glenmark receives ANDA approval for Amlodipine and Olmesartan Medoxomil Tablets

July 11, 2017

Glenmark Pharmaceuticals receives ANDA approval for Amlodipine and Olmesartan Medoxomil Tablets

July 7, 2017

Glenmark receives ANDA approval for Indomethacin Extended-Release Capsules USP, 75 mg

June 27, 2017

News

Search Result :-

Is an investigational new drug that has not been approved for commercial distribution in the United States.

July 25, 2017
Glenmark Pharmaceuticals receives ANDA approval for Desonide Cream, 0.05%

July 18, 2017
Glenmark Pharmaceuticals Enters Exclusive Agreement with Cyndea Pharma S.L. for Generic Soft-Gelatin Capsule Drug Products

July 11, 2017
Glenmark receives ANDA approval for Amlodipine and Olmesartan Medoxomil Tablets

July 7, 2017
Glenmark Pharmaceuticals receives ANDA approval for Amlodipine and Olmesartan Medoxomil Tablets

June 27, 2017
Glenmark receives ANDA approval for Indomethacin Extended-Release Capsules USP, 75 mg

US Media Contact

For media inquiries only, please contact Corporate Communications.
uscomms@glenmarkpharma.com

Investor Relations

For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.

POTASSIUM CHLORIDE EXTENDED RELEASE CAPSULES 750mg RECALL REIMBURSEMENT POLICY

Over-the-counter (OTC)

ACCESSIBLE PRODUCTS

Who We Are

Injectables

OUR GROWING LINE